VACCINEX, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Vaccinex, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2017 to Q2 2024.
  • Vaccinex, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$5.63M, a 20.2% increase year-over-year.
  • Vaccinex, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$17.8M, a 18.8% increase year-over-year.
  • Vaccinex, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$20.3M, a 2.2% decline from 2022.
  • Vaccinex, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$19.8M, a 11.5% increase from 2021.
  • Vaccinex, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$22.4M, a 22.4% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$17.8M -$5.63M +$1.43M +20.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$19.2M -$3.9M +$1.07M +21.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$20.3M -$3.32M +$1.76M +34.7% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-04-25
Q3 2023 -$22M -$4.91M -$153K -3.22% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$21.9M -$7.06M -$1.68M -31.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$20.2M -$4.96M -$367K -7.99% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$19.8M -$5.08M -$447K -9.65% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-04-25
Q3 2022 -$19.4M -$4.76M +$447K +8.59% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$19.8M -$5.38M +$586K +9.82% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$20.4M -$4.6M +$1.98M +30.1% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$22.4M -$4.63M +$1.82M +28.2% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-31
Q3 2021 -$24.2M -$5.21M +$3.55M +40.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$27.7M -$5.97M +$532K +8.18% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$28.3M -$6.57M +$575K +8.04% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$28.9M -$6.45M -$121K -1.91% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$28.7M -$8.75M -$1.11M -14.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 -$27.6M -$6.5M +$2.33M +26.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$29.9M -$7.15M +$1.92M +21.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$31.9M -$6.33M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$7.64M -$1.04M -15.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$8.83M -$2.22M -33.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$9.07M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q3 2018 -$6.6M -$1.06M -19.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$6.61M -$1.73M -35.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q3 2017 -$5.54M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$4.88M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.